RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME

Clinical trials for RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME explained in plain language.

Never miss a new study

Get alerted when new RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME trials appear

Sign up with your email to follow new studies for RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immune cells engineered to attack brain tumors enter human testing

Disease control Recruiting now

This early-stage trial tests a new treatment for adults with a returning, aggressive brain cancer called glioblastoma. The therapy uses the patient's own immune cells, modified to recognize and attack the cancer, and delivers them directly into the brain. The main goals are to se…

Matched conditions: RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 08, 2026 13:07 UTC

RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME

Get alerted when new RECURRENT IDH WILD-TYPE GLIOBLASTOMA MULTIFORME trials appear

Immune cells engineered to attack brain tumors enter human testing